APPLICATION
ANDA204816
TYPE
ANDA
ORIGINAL APPROVAL
2022-12-08
LATEST ACTION
2022-12-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
SILODOSINDiscontinued
SILODOSIN 8MG · CAPSULE · ORAL
SILODOSINDiscontinued
SILODOSIN 4MG · CAPSULE · ORAL
Approval history
2022-12-08UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.